ReviewNPJ Parkinson's disease2025

Targeting metabotropic glutamate receptors for symptomatic and disease-modifying treatment in Parkinson's disease.

Marika Alborghetti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.